SCHEMBL5771054

SCHEMBL5771054

Cc1ccc2occ(N3CCCCC3)c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
PRKDC P78527 1/20 0.47
TP53 P04637 1/20 0.47
ALDH1A1 P00352 5/20 0.43
TSHR P16473 2/20 0.43
NPC1 O15118 1/20 0.43
KMT2A Q03164 1/20 0.42
NR2E3 Q9Y5X4 1/20 0.42
RAB9A P51151 1/20 0.40
KDM4E B2RXH2 1/20 0.40
S1PR2 O95136 1/20 0.40
LMNA P02545 1/20 0.40
STAT6 P42226 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HIF1A Q16665 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.39
APP P05067 1/20 0.39
BCHE P06276 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8917729 0.84 PRKDC (0.45) MAPTPRKDCTP53ALDH1A1TSHR
SCHEMBL11321507 0.76 ALDH1A1 (0.57) PRKDCALDH1A1TSHRKMT2AKDM4E
SCHEMBL28241794 0.74 ALDH1A1 (0.57) PRKDCALDH1A1KDM4E
SCHEMBL8917934 0.72 MAPT (0.39) MAPTPRKDCTP53ALDH1A1TSHR
SCHEMBL30228418 0.71 ALDH1A1 (0.49) MAPTPRKDCALDH1A1TSHRNPC1
SCHEMBL23121380 0.70 DDB1 (0.49) PRKDCALDH1A1TSHRKMT2ANR2E3
SCHEMBL29592031 0.70 DDB1 (0.49) PRKDCALDH1A1TSHRKMT2ANR2E3
SCHEMBL1610105 0.70 PRKDC (0.46) MAPTPRKDCTP53ALDH1A1NPC1
SCHEMBL4885809 0.70 MAPT (0.68) MAPTTP53ALDH1A1NPC1KMT2A
SCHEMBL16727174 0.70 SLC18A3 (0.55) MAPTTP53ALDH1A1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-B1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF MITSUBISHI PHARMA CORP (JP) 2006-11-02 EP disclosed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed